Atlas Trials

Effects of 6 Weeks TOTUM-070 on Lipid Metabolism and Cardiovascular Health in Individuals at Increased Cardio-metabolic Risk

Clinical trial NCT05594979 · TERMINATED

Trial details

NCT number
NCT05594979
Sponsor
Valbiotis
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
HypercholesterolemiaCardiovascular Risk FactorDyslipidemiasAtherosclerosisCardio-metabolic Risk
Start date
2022-12-14
Primary completion
2023-09-06
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.